Nova Bone
Medical Devices, Nw Us Hwy 441, Alachua, , 32615, Florida, 13510, United States, 11-50 Employees
Phone Number: 38********
Who is NOVABONE
NovaBone Products was established in 2002 with a focus on developing bone graft substitutes based on advancements in biomedical engineering that would meet the specialized needs of orthop...
Read More
-
Headquarters: 13510 Nw Us Hwy 441, Alachua, Florida, 32615, United States
-
Date Founded: 2002
-
Employees: 11-50
-
Revenue: $25 Million to $50 Million
-
Active Tech Stack: See technologies
-
CEO:
Kim Sumner
Email
Phone
Industry: Medical Devices
SIC Code: 8731
|
NAICS Code: 541715 |
Show More
NovaBone Org Chart and Mapping
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding NovaBone
Answer: NovaBone's headquarters are located at Nw Us Hwy 441, Alachua, , 32615, Florida, 13510, United States
Answer: NovaBone's phone number is 38********
Answer: NovaBone's official website is https://novabone.com
Answer: NovaBone's revenue is $25 Million to $50 Million
Answer: NovaBone's SIC: 8731
Answer: NovaBone's NAICS: 541715
Answer: NovaBone has 11-50 employees
Answer: NovaBone is in Medical Devices
Answer: NovaBone contact info: Phone number: 38******** Website: https://novabone.com
Answer: NovaBone Products was established in 2002 with a focus on developing bone graft substitutes based on advancements in biomedical engineering that would meet the specialized needs of orthopedic and dental surgeons. Since its inception, our company has developed numerous formulations and delivery systems of its patented, bioactive technology platform that results in accelerated bone growth. In total, our exclusively formulated bone graft substitute has been used for the repair of osseous defects throughout the skeletal system for over a decade and used in over a million clinical applications with unparalleled success validating the safety and efficacy of NovaBone's technology. NovaBone was the first bioactive synthetic bone graft offered to the orthopedic community; the unique properties of the product formulation gave rise to the need to scientifically define its bone-forming process, and in 2005, the FDA authorized the term osteostimulation, as a way to describe how our products signal genetic pathways to accelerate natural regeneration of bone.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month